Propylthiouracil
CLINICAL USE
Hyperthyroidism
DOSE IN NORMAL RENAL FUNCTION
Initially: 200–400 mg dailyMaintenance dose: 50–150 mg daily
PHARMACOKINETICS
Molecular weight                           :170.2 %Protein binding                           :80 %Excreted unchanged in urine     : <2 Volume of distribution (L/kg)       :0.3–0.4half-life – normal/ESRD (hrs)      :1–2/8.5 DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
20 to 50     : Dose as in normal renal function 10 to 20     : 75% of normal dose and titrate to response <10           : 50% of normal dose and titrate to response DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Unknown dialysability. Dose as in GFR <10 mL/min HD                     :Not dialysed. Dose as in GFR <10 mL/minHDF/high flux   :Unknown dialysability. Dose as in GFR <10 mL/min CAV/VVHD      :Unknown dialysability. Dose as in GFR 10 to 20 mL/min IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsNone known ADMINISTRATION
Reconstition
– Route
Oral Rate of Administration
–Comments
– OTHER INFORMATION
Renally impaired patients are at a greater risk of cardiotoxicity and leucopenia.
See how to identify renal failure stages according to GFR calculation
See how to diagnose irreversible renal disease
Home